MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Eric RytkinIrina Vladimirovna BurePavel O BochkovKristina Anatolyevna AkmalovaKarin Badavievich MirzaevMarina S CherniaevaOlga Dmitrievna OstroumovaValeriy V SmirnovElena A GrishinaAnna G SaribekianIgor N SychevDmitry Alekseevich SychevPublished in: Drug metabolism and personalized therapy (2021)
This study has assessed new potential biomarkers for rivaroxaban therapeutic drug monitoring: miR-142 and miR-39.